Schizophrenia. [N Engl J Med. 2003] - PubMed

loading

Clozapine treatment of schizophrenia. [JAMA. 1995]
Clozapine treatment of schizophrenia.
Pickar D, Hsiao JK. JAMA. 1995 Sep 27; 274(12):981-3.
The D2 receptor: love it and leave it. [Mol Psychiatry. 1998]
The D2 receptor: love it and leave it.
Pickar D. Mol Psychiatry. 1998 Mar; 3(2):101-2.
Review Schizophrenia: an illness of distorted reality. [Biologist (London). 2000]
Review Schizophrenia: an illness of distorted reality.
Dean B. Biologist (London). 2000 Sep; 47(4):202-6.
Review [The dopaminergic hypothesis revisited]. [Encephale. 2006]
Review [The dopaminergic hypothesis revisited].
Guillin O. Encephale. 2006 Oct; 32(5 Pt 4):S908-11; discussion S912.
Review Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. [Mol Psychiatry. 1998]
Review Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
Seeman P, Tallerico T. Mol Psychiatry. 1998 Mar; 3(2):123-34.

The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia. [BMC Res Notes. 2012]
The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia.
Martins-de-Souza D, Alsaif M, Ernst A, Harris LW, Aerts N, Lenaerts I, Peeters PJ, Amess B, Rahmoune H, Bahn S, et al. BMC Res Notes. 2012 Mar 15; 5:146. Epub 2012 Mar 15.
Zic2 hypomorphic mutant mice as a schizophrenia model and ZIC2 mutations identified in schizophrenia patients. [Sci Rep. 2011]
Zic2 hypomorphic mutant mice as a schizophrenia model and ZIC2 mutations identified in schizophrenia patients.
Hatayama M, Ishiguro A, Iwayama Y, Takashima N, Sakoori K, Toyota T, Nozaki Y, Odaka YS, Yamada K, Yoshikawa T, et al. Sci Rep. 2011; 1:16. Epub 2011 Jun 17.
Alteration in the plasma concentration of a DAAO inhibitor, 3-methylpyrazole-5-carboxylic acid, in the ketamine-treated rats and the influence on the pharmacokinetics of plasma D-tryptophan. [Proc Jpn Acad Ser B Phys Biol ...]
Alteration in the plasma concentration of a DAAO inhibitor, 3-methylpyrazole-5-carboxylic acid, in the ketamine-treated rats and the influence on the pharmacokinetics of plasma D-tryptophan.
Haruta N, Iizuka H, Ishii K, Yoshihara S, Ichiba H, Fukushima T. Proc Jpn Acad Ser B Phys Biol Sci. 2011; 87(10):641-8.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Schizophrenia.
Schizophrenia.
N Engl J Med. 2003 Oct 30 ;349(18):1738-49.

PubMed
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initi...
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
N Engl J Med. 2003 Oct 30 ;349(18):1695-702.

PubMed
Müllerian-inhibiting substance inhibits rat Leydig cell regeneration after ethyl...
Müllerian-inhibiting substance inhibits rat Leydig cell regeneration after ethylene dimethanesulphonate ablation.
Biol Reprod. 2004 Mar ;70(3):600-7. Epub 2003 Oct 29 .

PubMed
A hypothalamic digoxin-mediated model for autism.
A hypothalamic digoxin-mediated model for autism.
Int J Neurosci. 2003 Nov ;113(11):1537-59.

PubMed
Adoptive cellular therapy for early cytomegalovirus infection after allogeneic s...
Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.
Lancet. 2003 Oct 25 ;362(9393):1375-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed